Glenmark Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLENMARK
NIFTY : NIFTY Midcap 100
NIFTY SECTOR : Nifty Pharma

About Company

Glenmark Pharmaceuticals Limited is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark’s ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark’s formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.

Market Cap. ₹ 50,331 Cr.

52 Week - High/Low ₹ 1,831/1,237

P/E Ratio 31.25

P/B Ratio 2.19

Enterprise Value ₹ 50,482 Cr.

ROE % 25.3

RSI Value 76.30

EMA 50 1578.19

EMA 200 1473.54

Market Cap. ₹ 50,331 Cr.

52 Week - High/Low ₹ 1,831/1,237

P/E Ratio 48.07

P/B Ratio 6.41

Enterprise Value ₹ 49,888 Cr.

ROE % -21.18

RSI Value 76.30

EMA 50 1578.19

EMA 200 1473.54

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us